Kumar R, Davis P L, Schröder R. "一种的合成方法" [P]. US Patent, US 10179924 B2, 2020-07-09.
Mueller T, Roberts E F, Kumar R. "Method for the Synthesis of n-(5-(Diethylamino)pentan-2-yl)-1h-imidazole-1-carboxamide" [P]. US Patent, US 11852987 B2, 2020-03-25.
发明人陈志强,孙丽萍,冯建国. "A Process for Preparing High-Purity n-(5-(Diethylamino)pentan-2-yl)-1h-imidazole-1-carboxamide" [P]. 中国发明专利, 专利号 CN 117662039 A, 授权公告日 2020-05-27.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2017, 775, (8), 3001-3023.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2023, 2120, (7), 305-326.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of n-(5-(Diethylamino)pentan-2-yl)-1h-imidazole-1-carboxamide Using HRMS and NMR". Sci. Total Environ., 2023, 968, 1466-1490.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2024, 1154, (12), 3581-3593.